Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Godt Smil Roskilde ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   1.3% 1.2% 1.5% 1.4% 1.9% 2.5% 10.0% 10.0%   Credit score (0-100)   82 83 76 77 70 61 25 25   Credit rating   A A A A A BBB BB BB   Credit limit (kDKK)   71.6 145.2 26.1 47.0 2.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   9,158 12,970 14,857 13,859 13,164 15,537 0.0 0.0   EBITDA   989 3,044 3,691 2,417 3,440 4,469 0.0 0.0   EBIT   492 2,538 3,177 1,890 2,912 4,091 0.0 0.0   Pre-tax profit (PTP)   452.4 2,524.9 3,158.7 1,874.7 2,881.1 4,070.6 0.0 0.0   Net earnings   352.4 1,969.0 2,458.3 1,461.0 2,245.6 3,172.5 0.0 0.0   Pre-tax profit without non-rec. items   452 2,525 3,159 1,875 2,881 4,071 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,340 1,948 1,573 1,528 1,056 861 0.0 0.0   Shareholders equity total   1,956 2,425 2,133 1,594 2,090 1,812 1,437 1,437   Interest-bearing liabilities   887 85.6 301 214 124 31.3 0.0 0.0   Balance sheet total (assets)   4,654 5,292 5,643 5,033 4,074 4,136 1,437 1,437   Net Debt   362 -1,768 -2,337 -2,062 -1,623 -2,237 -1,437 -1,437     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   9,158 12,970 14,857 13,859 13,164 15,537 0.0 0.0   Gross profit growth   9.0% 41.6% 14.6% -6.7% -5.0% 18.0% -100.0% 0.0%   Employees   16 15 17 18 14 15 0 0   Employee growth %   23.1% -6.3% 13.3% 5.9% -22.2% 7.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,654 5,292 5,643 5,033 4,074 4,136 1,437 1,437   Balance sheet change%   11.7% 13.7% 6.6% -10.8% -19.1% 1.5% -65.3% 0.0%   Added value   988.9 3,044.5 3,690.6 2,417.2 3,438.6 4,469.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -364 -899 -889 -572 -1,001 -574 -861 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.4% 19.6% 21.4% 13.6% 22.1% 26.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.3% 51.3% 58.4% 35.7% 64.3% 100.3% 0.0% 0.0%   ROI %   15.8% 78.2% 102.7% 69.6% 124.3% 195.5% 0.0% 0.0%   ROE %   19.8% 89.9% 107.9% 78.4% 121.9% 162.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   44.2% 48.9% 40.3% 33.6% 54.2% 44.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   36.6% -58.1% -63.3% -85.3% -47.2% -50.0% 0.0% 0.0%   Gearing %   45.3% 3.5% 14.1% 13.4% 5.9% 1.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.9% 5.6% 19.2% 12.7% 28.0% 60.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 1.4 1.4 1.2 2.1 1.7 0.0 0.0   Current Ratio   0.7 1.4 1.5 1.2 2.1 1.8 0.0 0.0   Cash and cash equivalent   524.5 1,853.9 2,637.9 2,275.6 1,747.0 2,267.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -553.8 948.2 1,248.6 620.2 1,494.9 1,363.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   62 203 217 134 246 298 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   62 203 217 134 246 298 0 0   EBIT / employee   31 169 187 105 208 273 0 0   Net earnings / employee   22 131 145 81 160 212 0 0